Clinical Trial Update: Beta Cell Function Tests Over Time In Patients With T2dm Randomized To Metformin Or Rosiglitazone [NA]

View source ↗

Summary

A randomized trial in type 2 diabetes mellitus comparing metformin vs rosiglitazone reports beta cell function tests over time; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Rosiglitazone (rosiglitazone)
• metformin (metformin)

Snippet

Sponsor: Pfizer | Conditions: Type 2 Diabetes Mellitus | NA | Status: TERMINATED